Afrezza Launches Trial to Bring Inhaled Insulin to Children With Type 1 Diabetes
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
Modular Medical Announces it's Insulin Pump Is Close to Commercial Launch
The company has began production of validation lots for its tubeless insulin pump aimed at “almost‐pumpers,” with plans for an early 2026 commercial debut still on track.
As more insulin pumps move to pharmacy benefits, switching systems is easier than ever—but it’s also exposing serious gaps in safety, training, and support.
Here are the most listened to Diabetech podcast episodes of 2025, featuring expert interviews, diabetes tech and cure resear, and the future of diabetes technology.
How to Optimize Basal Insulin Settings for More Stable Glucose
I sat down with CDCES Gary Scheiner to discuss why basal insulin matters, how to know when it's off, and what stable basal looks like for insulin pumps and MDI.
